The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care

In this study, we sought to estimate the societal cost of illness in dementia in Sweden in 2012 using different costing approaches to highlight methodological issues. We conducted a prevalence-based cost-of-illness study with a societal perspective. The societal costs of dementia in Sweden in 2012 w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ALZHEIMERS RESEARCH & THERAPY 2016-11, Vol.8 (1), p.59-59, Article 59
Hauptverfasser: Wimo, Anders, Jönsson, Linus, Fratiglioni, Laura, Sandman, Per Olof, Gustavsson, Anders, Sköldunger, Anders, Johansson, Lennarth
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 59
container_issue 1
container_start_page 59
container_title ALZHEIMERS RESEARCH & THERAPY
container_volume 8
creator Wimo, Anders
Jönsson, Linus
Fratiglioni, Laura
Sandman, Per Olof
Gustavsson, Anders
Sköldunger, Anders
Johansson, Lennarth
description In this study, we sought to estimate the societal cost of illness in dementia in Sweden in 2012 using different costing approaches to highlight methodological issues. We conducted a prevalence-based cost-of-illness study with a societal perspective. The societal costs of dementia in Sweden in 2012 were SEK 62.9 billion (approximately €7.2 billion, approximately US$9.0 billion) or SEK 398,000 per person with dementia (approximately €45,000, approximately US$57,000). By far the most important cost item is the cost of institutional care: about 60% of the costs. In the sensitivity analysis, different quantification and costing approaches for informal care resulted in a great variation in the total societal cost, ranging from SEK 60 billion (€6.8 billion, US$8.6 billion) to SEK 124 billion (€14.1 billion, US$17.8 billion). The societal costs of dementia are very high. The cost per person with dementia has decreased somewhat, mainly because of de-institutionalisation. The majority of the costs occur in the social care sector, but the costing of informal care is crucial for the cost estimates.
doi_str_mv 10.1186/s13195-016-0215-9
format Article
fullrecord <record><control><sourceid>gale_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_500364</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A474150980</galeid><sourcerecordid>A474150980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c750t-4cd4a0f6509cecf447e88a9d27c5d3c6bef2dc00a04836ddad69fb249f97fc563</originalsourceid><addsrcrecordid>eNqNk12L1DAUhoso7rr6A7yRgCBe2DUfbdrcCMP6CQteuHobMslJG02b2aadxX9vwozrDKgsveghed6X03P6FsVTgs8JafnrSBgRdYkJLzEldSnuFaekqdtSEMHuH9QnxaMYv2PMOW2rh8UJbUTLsWCnxeaqBxSDdjArj3SIc0TBIgMDjLNTyI3oyw0YGBHFhKISTeBhq0YNSI0GDTD3wQQfOqezvlfew9hBzMKt8osbu1TaMA35Wk3wuHhglY_wZP8-K76-f3d18bG8_Pzh08XqstRNjeey0qZS2PIaCw3aVlUDbauEoY2uDdN8DZYajbHCVcu4McpwYde0ElY0VtecnRXlzjfewGZZy83kBjX9lEE5uT_6kSqQNcaMV4l_9U_-rfu2kmHq5LJIRlJL-L_2f_BhkWlFBLO72ceMC0bu2I2fF8kJESLhb3Z4YgcwOu1uUv5IdXwzul52YStrwikWbTJ4uTeYwvUCcZaDixq8VyOEJUrS1pQLWre5tec7tFMeZN5tctQZl6uqqfJ42jyf879Q6Ul_ltNhBOvS-ZHgxYGgB-XnPga_zC6M8RgkO1BPIcYJ7O1nEixzLOQuFjLFQuZYyDyfZ4fzuVX8zgH7BVjHCYE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1852692584</pqid></control><display><type>article</type><title>The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SWEPUB Freely available online</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Wimo, Anders ; Jönsson, Linus ; Fratiglioni, Laura ; Sandman, Per Olof ; Gustavsson, Anders ; Sköldunger, Anders ; Johansson, Lennarth</creator><creatorcontrib>Wimo, Anders ; Jönsson, Linus ; Fratiglioni, Laura ; Sandman, Per Olof ; Gustavsson, Anders ; Sköldunger, Anders ; Johansson, Lennarth</creatorcontrib><description>In this study, we sought to estimate the societal cost of illness in dementia in Sweden in 2012 using different costing approaches to highlight methodological issues. We conducted a prevalence-based cost-of-illness study with a societal perspective. The societal costs of dementia in Sweden in 2012 were SEK 62.9 billion (approximately €7.2 billion, approximately US$9.0 billion) or SEK 398,000 per person with dementia (approximately €45,000, approximately US$57,000). By far the most important cost item is the cost of institutional care: about 60% of the costs. In the sensitivity analysis, different quantification and costing approaches for informal care resulted in a great variation in the total societal cost, ranging from SEK 60 billion (€6.8 billion, US$8.6 billion) to SEK 124 billion (€14.1 billion, US$17.8 billion). The societal costs of dementia are very high. The cost per person with dementia has decreased somewhat, mainly because of de-institutionalisation. The majority of the costs occur in the social care sector, but the costing of informal care is crucial for the cost estimates.</description><identifier>ISSN: 1758-9193</identifier><identifier>EISSN: 1758-9193</identifier><identifier>DOI: 10.1186/s13195-016-0215-9</identifier><identifier>PMID: 27986093</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Age Distribution ; Alzheimer's disease ; Analysis ; Cost of Illness ; Costing study ; Dementia ; Dementia - economics ; Dementia - epidemiology ; Dementia - nursing ; Economic aspects ; Female ; Health Care Costs ; Humans ; Institutionalization - economics ; Male ; Nursing ; Omvårdnad ; Patient Care - economics ; Prevalence ; Retrospective Studies ; Sensitivity and Specificity ; Social aspects ; Sweden ; Sweden - epidemiology</subject><ispartof>ALZHEIMERS RESEARCH &amp; THERAPY, 2016-11, Vol.8 (1), p.59-59, Article 59</ispartof><rights>COPYRIGHT 2016 BioMed Central Ltd.</rights><rights>The Author(s). 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c750t-4cd4a0f6509cecf447e88a9d27c5d3c6bef2dc00a04836ddad69fb249f97fc563</citedby><cites>FETCH-LOGICAL-c750t-4cd4a0f6509cecf447e88a9d27c5d3c6bef2dc00a04836ddad69fb249f97fc563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5162098/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5162098/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,550,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27986093$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-61199$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-139314$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-131103$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-315090$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:134947742$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Wimo, Anders</creatorcontrib><creatorcontrib>Jönsson, Linus</creatorcontrib><creatorcontrib>Fratiglioni, Laura</creatorcontrib><creatorcontrib>Sandman, Per Olof</creatorcontrib><creatorcontrib>Gustavsson, Anders</creatorcontrib><creatorcontrib>Sköldunger, Anders</creatorcontrib><creatorcontrib>Johansson, Lennarth</creatorcontrib><title>The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care</title><title>ALZHEIMERS RESEARCH &amp; THERAPY</title><addtitle>Alzheimers Res Ther</addtitle><description>In this study, we sought to estimate the societal cost of illness in dementia in Sweden in 2012 using different costing approaches to highlight methodological issues. We conducted a prevalence-based cost-of-illness study with a societal perspective. The societal costs of dementia in Sweden in 2012 were SEK 62.9 billion (approximately €7.2 billion, approximately US$9.0 billion) or SEK 398,000 per person with dementia (approximately €45,000, approximately US$57,000). By far the most important cost item is the cost of institutional care: about 60% of the costs. In the sensitivity analysis, different quantification and costing approaches for informal care resulted in a great variation in the total societal cost, ranging from SEK 60 billion (€6.8 billion, US$8.6 billion) to SEK 124 billion (€14.1 billion, US$17.8 billion). The societal costs of dementia are very high. The cost per person with dementia has decreased somewhat, mainly because of de-institutionalisation. The majority of the costs occur in the social care sector, but the costing of informal care is crucial for the cost estimates.</description><subject>Age Distribution</subject><subject>Alzheimer's disease</subject><subject>Analysis</subject><subject>Cost of Illness</subject><subject>Costing study</subject><subject>Dementia</subject><subject>Dementia - economics</subject><subject>Dementia - epidemiology</subject><subject>Dementia - nursing</subject><subject>Economic aspects</subject><subject>Female</subject><subject>Health Care Costs</subject><subject>Humans</subject><subject>Institutionalization - economics</subject><subject>Male</subject><subject>Nursing</subject><subject>Omvårdnad</subject><subject>Patient Care - economics</subject><subject>Prevalence</subject><subject>Retrospective Studies</subject><subject>Sensitivity and Specificity</subject><subject>Social aspects</subject><subject>Sweden</subject><subject>Sweden - epidemiology</subject><issn>1758-9193</issn><issn>1758-9193</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>D8T</sourceid><recordid>eNqNk12L1DAUhoso7rr6A7yRgCBe2DUfbdrcCMP6CQteuHobMslJG02b2aadxX9vwozrDKgsveghed6X03P6FsVTgs8JafnrSBgRdYkJLzEldSnuFaekqdtSEMHuH9QnxaMYv2PMOW2rh8UJbUTLsWCnxeaqBxSDdjArj3SIc0TBIgMDjLNTyI3oyw0YGBHFhKISTeBhq0YNSI0GDTD3wQQfOqezvlfew9hBzMKt8osbu1TaMA35Wk3wuHhglY_wZP8-K76-f3d18bG8_Pzh08XqstRNjeey0qZS2PIaCw3aVlUDbauEoY2uDdN8DZYajbHCVcu4McpwYde0ElY0VtecnRXlzjfewGZZy83kBjX9lEE5uT_6kSqQNcaMV4l_9U_-rfu2kmHq5LJIRlJL-L_2f_BhkWlFBLO72ceMC0bu2I2fF8kJESLhb3Z4YgcwOu1uUv5IdXwzul52YStrwikWbTJ4uTeYwvUCcZaDixq8VyOEJUrS1pQLWre5tec7tFMeZN5tctQZl6uqqfJ42jyf879Q6Ul_ltNhBOvS-ZHgxYGgB-XnPga_zC6M8RgkO1BPIcYJ7O1nEixzLOQuFjLFQuZYyDyfZ4fzuVX8zgH7BVjHCYE</recordid><startdate>20161118</startdate><enddate>20161118</enddate><creator>Wimo, Anders</creator><creator>Jönsson, Linus</creator><creator>Fratiglioni, Laura</creator><creator>Sandman, Per Olof</creator><creator>Gustavsson, Anders</creator><creator>Sköldunger, Anders</creator><creator>Johansson, Lennarth</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><scope>ABAVF</scope><scope>DG7</scope><scope>ADHXS</scope><scope>D93</scope><scope>ACNBI</scope><scope>DF2</scope></search><sort><creationdate>20161118</creationdate><title>The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care</title><author>Wimo, Anders ; Jönsson, Linus ; Fratiglioni, Laura ; Sandman, Per Olof ; Gustavsson, Anders ; Sköldunger, Anders ; Johansson, Lennarth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c750t-4cd4a0f6509cecf447e88a9d27c5d3c6bef2dc00a04836ddad69fb249f97fc563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Age Distribution</topic><topic>Alzheimer's disease</topic><topic>Analysis</topic><topic>Cost of Illness</topic><topic>Costing study</topic><topic>Dementia</topic><topic>Dementia - economics</topic><topic>Dementia - epidemiology</topic><topic>Dementia - nursing</topic><topic>Economic aspects</topic><topic>Female</topic><topic>Health Care Costs</topic><topic>Humans</topic><topic>Institutionalization - economics</topic><topic>Male</topic><topic>Nursing</topic><topic>Omvårdnad</topic><topic>Patient Care - economics</topic><topic>Prevalence</topic><topic>Retrospective Studies</topic><topic>Sensitivity and Specificity</topic><topic>Social aspects</topic><topic>Sweden</topic><topic>Sweden - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wimo, Anders</creatorcontrib><creatorcontrib>Jönsson, Linus</creatorcontrib><creatorcontrib>Fratiglioni, Laura</creatorcontrib><creatorcontrib>Sandman, Per Olof</creatorcontrib><creatorcontrib>Gustavsson, Anders</creatorcontrib><creatorcontrib>Sköldunger, Anders</creatorcontrib><creatorcontrib>Johansson, Lennarth</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><collection>SWEPUB Stockholms universitet full text</collection><collection>SWEPUB Stockholms universitet</collection><collection>SWEPUB Umeå universitet full text</collection><collection>SWEPUB Umeå universitet</collection><collection>SWEPUB Uppsala universitet full text</collection><collection>SWEPUB Uppsala universitet</collection><jtitle>ALZHEIMERS RESEARCH &amp; THERAPY</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wimo, Anders</au><au>Jönsson, Linus</au><au>Fratiglioni, Laura</au><au>Sandman, Per Olof</au><au>Gustavsson, Anders</au><au>Sköldunger, Anders</au><au>Johansson, Lennarth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care</atitle><jtitle>ALZHEIMERS RESEARCH &amp; THERAPY</jtitle><addtitle>Alzheimers Res Ther</addtitle><date>2016-11-18</date><risdate>2016</risdate><volume>8</volume><issue>1</issue><spage>59</spage><epage>59</epage><pages>59-59</pages><artnum>59</artnum><issn>1758-9193</issn><eissn>1758-9193</eissn><abstract>In this study, we sought to estimate the societal cost of illness in dementia in Sweden in 2012 using different costing approaches to highlight methodological issues. We conducted a prevalence-based cost-of-illness study with a societal perspective. The societal costs of dementia in Sweden in 2012 were SEK 62.9 billion (approximately €7.2 billion, approximately US$9.0 billion) or SEK 398,000 per person with dementia (approximately €45,000, approximately US$57,000). By far the most important cost item is the cost of institutional care: about 60% of the costs. In the sensitivity analysis, different quantification and costing approaches for informal care resulted in a great variation in the total societal cost, ranging from SEK 60 billion (€6.8 billion, US$8.6 billion) to SEK 124 billion (€14.1 billion, US$17.8 billion). The societal costs of dementia are very high. The cost per person with dementia has decreased somewhat, mainly because of de-institutionalisation. The majority of the costs occur in the social care sector, but the costing of informal care is crucial for the cost estimates.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>27986093</pmid><doi>10.1186/s13195-016-0215-9</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1758-9193
ispartof ALZHEIMERS RESEARCH & THERAPY, 2016-11, Vol.8 (1), p.59-59, Article 59
issn 1758-9193
1758-9193
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_500364
source MEDLINE; Springer Nature - Complete Springer Journals; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; SWEPUB Freely available online; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Age Distribution
Alzheimer's disease
Analysis
Cost of Illness
Costing study
Dementia
Dementia - economics
Dementia - epidemiology
Dementia - nursing
Economic aspects
Female
Health Care Costs
Humans
Institutionalization - economics
Male
Nursing
Omvårdnad
Patient Care - economics
Prevalence
Retrospective Studies
Sensitivity and Specificity
Social aspects
Sweden
Sweden - epidemiology
title The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T21%3A47%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20societal%20costs%20of%20dementia%20in%20Sweden%202012%20-%20relevance%20and%20methodological%20challenges%20in%20valuing%20informal%20care&rft.jtitle=ALZHEIMERS%20RESEARCH%20&%20THERAPY&rft.au=Wimo,%20Anders&rft.date=2016-11-18&rft.volume=8&rft.issue=1&rft.spage=59&rft.epage=59&rft.pages=59-59&rft.artnum=59&rft.issn=1758-9193&rft.eissn=1758-9193&rft_id=info:doi/10.1186/s13195-016-0215-9&rft_dat=%3Cgale_swepu%3EA474150980%3C/gale_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1852692584&rft_id=info:pmid/27986093&rft_galeid=A474150980&rfr_iscdi=true